Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD. Yen FS, Hsu CC, Wei JC, Tsai FJ, et al. Thorax 2024;79:1017-1023.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yen FS, Hsu CC, Wei JC, Tsai FJ, et al. Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD. Thorax 2024;79:1017-1023.
PMID: 39353727